News Personalised Vaccines Move Closer in Ovarian Cancer CareNiamh DoyleOctober 16, 2026 An early trial found a personalised NeoVax vaccine with nivolumab feasible and acceptably safe in platinum-sensitive ovarian cancer patients.
